BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32701208)

  • 1. Predictive values of initial semi-quantitative assessment of relative afferent pupillary defect for neovascularization in central retinal vein occlusion.
    Ducloyer JB; Bensaber S; Khanna RK; Cochard C; Lebreton O; Le Meur G; Lebranchu P; Arsene S; Weber M
    Acta Ophthalmol; 2021 Mar; 99(2):215-220. PubMed ID: 32701208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative afferent pupillary defect and edge light pupil cycle time in the early differentiation of central retinal vein occlusion.
    Menon V; Nachiketa MS; Kumar A
    Indian J Ophthalmol; 1995 Sep; 43(3):127-30. PubMed ID: 8822487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early panretinal photocoagulation for ERG-verified ischaemic central retinal vein occlusion.
    Kjeka O; Jansson RW; Bredrup C; Krohn J
    Acta Ophthalmol; 2013 Feb; 91(1):37-41. PubMed ID: 22176715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroretinography in central retinal vein occlusion. Correlation of electroretinographic changes with pupillary abnormalities.
    Hayreh SS; Klugman MR; Podhajsky P; Kolder HE
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(6):549-61. PubMed ID: 2483144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and infrared pupillometry in central retinal vein occlusion.
    Bloom PA; Papakostopoulos D; Gogolitsyn Y; Leenderz JA; Papakostopoulos S; Grey RH
    Br J Ophthalmol; 1993 Feb; 77(2):75-80. PubMed ID: 8435422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion.
    Rong AJ; Swaminathan SS; Vanner EA; Parrish RK
    Am J Ophthalmol; 2019 Aug; 204():62-69. PubMed ID: 30862502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion].
    Kabesha TB; Glacet-Bernard A; Rostaqui O; Souied EH
    J Fr Ophtalmol; 2015 May; 38(5):414-20. PubMed ID: 25956562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranibizumab in preproliferative (ischemic) central retinal vein occlusion: the rubeosis anti-VEGF (RAVE) trial.
    Brown DM; Wykoff CC; Wong TP; Mariani AF; Croft DE; Schuetzle KL;
    Retina; 2014 Sep; 34(9):1728-35. PubMed ID: 24914476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors.
    McAllister IL; Douglas JP; Constable IJ; Yu DY
    Am J Ophthalmol; 1998 Aug; 126(2):219-29. PubMed ID: 9727516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroretinography as a prognostic indicator or neovascularisation in CRVO.
    Morrell AJ; Thompson DA; Gibson JM; Kritzinger EE; Drasdo N
    Eye (Lond); 1991; 5 ( Pt 3)():362-8. PubMed ID: 1955061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal Nonperfusion in the Posterior Pole Is Associated With Increased Risk of Neovascularization in Central Retinal Vein Occlusion.
    Nicholson L; Vazquez-Alfageme C; Patrao NV; Triantafyllopolou I; Bainbridge JW; Hykin PG; Sivaprasad S
    Am J Ophthalmol; 2017 Oct; 182():118-125. PubMed ID: 28739419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A complication of ischemic branch retinal vein occlusion.
    Ranjith PC; Giridhar A
    Indian J Ophthalmol; 2019 Feb; 67(2):276. PubMed ID: 30672491
    [No Abstract]   [Full Text] [Related]  

  • 13. Ocular neovascularization associated with central and hemicentral retinal vein occlusion.
    Hayreh SS; Zimmerman MB
    Retina; 2012 Sep; 32(8):1553-65. PubMed ID: 22495331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panretinal photocoagulation and photodynamic therapy for anterior segment neovascularization secondary to ischemic central retinal vein occlusion.
    Parodi MB; Friberg TR; Pedio M; Fiotti N; Di Stefano G; Ravalico G
    Ophthalmic Surg Lasers Imaging; 2007; 38(2):94-9. PubMed ID: 17396687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for central retinal vein occlusion: an evidence-based systematic review.
    Mohamed Q; McIntosh RL; Saw SM; Wong TY
    Ophthalmology; 2007 Mar; 114(3):507-19, 524. PubMed ID: 17324695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab (Avastin) as a treatment of the neovascular complications of laser-induced chorioretinal anastomosis for nonischaemic central retinal vein occlusion.
    Fong KC; Barry C; McAllister IL
    Clin Exp Ophthalmol; 2009 Jul; 37(5):485-9. PubMed ID: 19624345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
    Feltgen N; Junker B; Agostini H; Hansen LL
    Ophthalmology; 2007 Apr; 114(4):716-23. PubMed ID: 17141322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of laser coagulation of central retinal vein occlusion].
    Lang GE
    Klin Monbl Augenheilkd; 1993 Oct; 203(4):247-51. PubMed ID: 7509425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitrectomy and panretinal photocoagulation reduces the occurrence of neovascular glaucoma in central retinal vein occlusion with vitreous hemorrhage.
    Chuang LH; Wang NK; Chen YP; Yeung L; Hwang YS; Chen KJ; Wu WC; Chen TL; Lai CC
    Retina; 2013 Apr; 33(4):798-802. PubMed ID: 23114407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser therapy for central retinal vein obstruction.
    Finkelstein D
    Curr Opin Ophthalmol; 1996 Jun; 7(3):80-3. PubMed ID: 10163466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.